MANPREET SINGH: Open Payments
NPI 1659089274 · BERWYN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$525 in 16 payments from 8 companies in 2025. Trend: 2023 $1,170 · 2024 $1,804 · 2025 $525
Food & beverage: $525
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $172 |
| Otsuka America Pharmaceutical, Inc. | 5 | $162 |
| E.R. Squibb & Sons, L.L.C. | 2 | $47 |
| Collegium Pharmaceutical, Inc. | 2 | $38 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| Janssen Pharmaceuticals, Inc | 1 | $32 |
| Alkermes, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: CAPLYTA, ABILIFY MAINTENA, COBENFY, Jornay PM, REXULTI, Auvelity, INVEGA SUSTENNA, LYBALVI.
Industry payments across IL — which companies pay providers there.
